Impact of Morphine withdrawal on genes related to the TLR2 pathway expressed in the Prefrontal Cortex

Bridget Truitt1, Junyi Tao1, Sabita Roy1

  • 1Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.

Science Progress
|September 4, 2024
PubMed

Insights

Opioid withdrawal symptoms drive relapse, but mechanisms remain unclear. This study reveals toll-like receptor 2 (TLR2) plays a key role in morphine withdrawal, suggesting it as a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Opioid use disorder (OUD) is a major public health crisis, with withdrawal symptoms contributing significantly to relapse.
  • Current therapeutic options for mitigating opioid withdrawal are limited due to an incomplete understanding of underlying mechanisms.
  • Previous research suggests a link between morphine-induced microbial changes and withdrawal responses mediated by toll-like receptor 2 (TLR2).

Purpose of the Study:

  • To investigate the role of toll-like receptor 2 (TLR2) in the mechanisms of morphine withdrawal.
  • To explore TLR2 signaling pathways in the pre-frontal cortex during morphine withdrawal.
  • To evaluate the potential of TLR2 as a therapeutic target for managing opioid withdrawal.

Main Methods:

  • Transcriptome analysis of the pre-frontal cortex in morphine withdrawal models.
  • Assessment of TLR2 pathway gene expression following antibiotic treatment.
  • Evaluation of morphine withdrawal effects in a whole-body TLR2 knockout mouse model.

Main Results:

  • Increased expression of TLR2 signaling pathway genes was observed in the pre-frontal cortex of animals undergoing morphine withdrawal.
  • Antibiotic treatment modulated TLR2-related gene expression, partially reversing morphine-induced effects.
  • Morphine withdrawal-induced gene expression changes were significantly attenuated in TLR2 knockout mice.

Conclusions:

  • Toll-like receptor 2 (TLR2) is integral to the mechanisms underlying morphine withdrawal.
  • Targeting TLR2 may offer a novel therapeutic strategy to alleviate opioid withdrawal symptoms and associated comorbidities.
  • Further research into TLR2-mediated pathways could lead to improved treatments for opioid use disorder.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
589
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
251